Cabaletta Bio Inc (NASDAQ:CABA)’s traded shares stood at 1.78 million during the last session, with the company’s beta value hitting 2.41. At the close of trading, the stock’s price was $17.06, to imply a decrease of -0.52% or -$0.09 in intraday trading. The CABA share’s 52-week high remains $26.35, putting it -54.45% down since that peak but still an impressive 59.32% since price per share fell to its 52-week low of $6.94. The company has a valuation of $731.02M, with an average of 1.34 million shares in intraday trading volume over the past 10 days and average of 912.01K shares over the past 3 months.
Cabaletta Bio Inc (NASDAQ:CABA) trade information
After registering a -0.52% downside in the last session, Cabaletta Bio Inc (CABA) has traded red over the past five days. The stock hit a weekly high of 18.41, dropping -0.52% in its intraday price action. The 5-day price performance for the stock is -2.74%, and -25.99% over 30 days. With these gigs, the year-to-date price performance is -24.85%. Short interest in Cabaletta Bio Inc (NASDAQ:CABA) saw shorts transact 7.09 million shares and set a 8.1 days time to cover.
Cabaletta Bio Inc (CABA) estimates and forecasts
Looking at statistics comparing Cabaletta Bio Inc share performance against respective industry, we note that the company has underperformed competitors. Cabaletta Bio Inc (CABA) shares are 16.05% up over the last 6 months, with its year-to-date growth rate lower than industry average at -9.70% against 13.00%. Revenue is forecast to shrink -6.70% this quarter before falling -27.00% for the next one.
CABA Dividends
Cabaletta Bio Inc has its next earnings report out between May 09 and May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Cabaletta Bio Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Cabaletta Bio Inc (NASDAQ:CABA)’s Major holders
Cabaletta Bio Inc insiders hold 3.14% of total outstanding shares, with institutional holders owning 101.54% of the shares at 104.83% float percentage. In total, 101.54% institutions holds shares in the company, led by Fred Alger Management, LLC. As of Jun 29, 2023, the company held over 4.57 million shares (or 11.49% of shares), all amounting to roughly $59.04 million.
The next major institution holding the largest number of shares is Adage Capital Partners GP L.L.C. with 3.27 million shares, or about 8.21% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $42.17 million.
We also have Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Cabaletta Bio Inc (CABA) shares. Going by data provided on Jul 30, 2023, Alger Small Cap Focus Fund holds roughly 3.22 million shares. This is just over 8.09% of the total shares, with a market valuation of $43.87 million. Data from the same date shows that the other fund manager holds a little less at 1.14 million, or 2.87% of the shares, all valued at about 14.75 million.
